Lineage Cell Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $18.2M | $94.7M | $42.2M |
| FY2016 | $12.1M | $142.6M | $22.1M |
| FY2017 | $9.0M | $173.2M | $36.8M |
| FY2018 | $9.4M | $101.7M | $23.6M |
| FY2019 | $14.2M | $125.5M | $9.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $18.2M | $94.7M | $42.2M |
| FY2016 | $12.1M | $142.6M | $22.1M |
| FY2017 | $9.0M | $173.2M | $36.8M |
| FY2018 | $9.4M | $101.7M | $23.6M |
| FY2019 | $14.2M | $125.5M | $9.5M |